- Home
- PLCE vs CCCC Comparison
PLCE vs CCCC Comparison
Compare PLCE & CCCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLCE
- CCCC
- Stock Information
- Founded
- PLCE 1969
- CCCC 2015
- Country
- PLCE United States
- CCCC United States
- Employees
- PLCE N/A
- CCCC N/A
- Industry
- PLCE Clothing/Shoe/Accessory Stores
- CCCC Biotechnology: Pharmaceutical Preparations
- Sector
- PLCE Consumer Discretionary
- CCCC Health Care
- Exchange
- PLCE Nasdaq
- CCCC Nasdaq
- Market Cap
- PLCE 128.9M
- CCCC 104.4M
- IPO Year
- PLCE 1997
- CCCC 2020
- Fundamental
- Price
- PLCE $5.00
- CCCC $2.26
- Analyst Decision
- PLCE Hold
- CCCC Buy
- Analyst Count
- PLCE 1
- CCCC 3
- Target Price
- PLCE $6.00
- CCCC $12.00
- AVG Volume (30 Days)
- PLCE 782.5K
- CCCC 1.6M
- Earning Date
- PLCE 06-06-2025
- CCCC 07-31-2025
- Dividend Yield
- PLCE N/A
- CCCC N/A
- EPS Growth
- PLCE N/A
- CCCC N/A
- EPS
- PLCE N/A
- CCCC N/A
- Revenue
- PLCE $1,360,516,000.00
- CCCC $39,783,000.00
- Revenue This Year
- PLCE N/A
- CCCC N/A
- Revenue Next Year
- PLCE $1.47
- CCCC N/A
- P/E Ratio
- PLCE N/A
- CCCC N/A
- Revenue Growth
- PLCE N/A
- CCCC 98.56
- 52 Week Low
- PLCE $3.66
- CCCC $1.09
- 52 Week High
- PLCE $19.74
- CCCC $7.66
- Technical
- Relative Strength Index (RSI)
- PLCE 56.41
- CCCC 63.62
- Support Level
- PLCE $4.85
- CCCC $1.36
- Resistance Level
- PLCE $4.72
- CCCC $2.17
- Average True Range (ATR)
- PLCE 0.29
- CCCC 0.15
- MACD
- PLCE 0.18
- CCCC 0.05
- Stochastic Oscillator
- PLCE 97.13
- CCCC 67.11
About PLCE Children's Place Inc. (The)
Children's Place Inc operate an omni-channel children's specialty portfolio of brands in North America. It designs, contract to manufacture, and sell fashionable, high-quality apparel, accessories and footwear predominantly at value prices under proprietary The Children's Place, Place, Baby Place, Gymboree, Sugar & Jade, and PJ Place brand names. The Company classifies its business into two segments: The Children's Place U.S. and The Children's Place International.
About CCCC C4 Therapeutics Inc.
C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.